To examine the CXCL11 which highly secreted from SCD-upregulated CD4+ T cells activated the CD8+ T cells dependent on CXCR3, we evaluated the activation markers for CD8+ T cells after treatment with rCXCL11 and CXCR3 inhibitor. The gene discussed is CXCR3; the disease is Schnyder corneal dystrophy.